These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7888694)

  • 1. Islet cell antibodies are associated with beta-cell failure also in obese adult onset diabetic patients.
    Gottsäter A; Landin-Olsson M; Lernmark A; Fernlund P; Sundkvist G
    Acta Diabetol; 1994 Dec; 31(4):226-31. PubMed ID: 7888694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
    Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
    Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender, autoantibodies, and obesity in newly diagnosed diabetic patients aged 40-75 years.
    Wroblewski M; Gottsater A; Lindgarde F; Fernlund P; Sundkvist G
    Diabetes Care; 1998 Feb; 21(2):250-5. PubMed ID: 9539991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes.
    Borg H; Gottsäter A; Fernlund P; Sundkvist G
    Diabetes; 2002 Jun; 51(6):1754-62. PubMed ID: 12031962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.
    Nakanishi K; Kobayashi T; Miyashita H; Ohkubo M; Sugimoto T; Murase T; Kosaka K; Inouye K; Kono M
    Metabolism; 1990 Sep; 39(9):925-30. PubMed ID: 2202883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
    Turner R; Stratton I; Horton V; Manley S; Zimmet P; Mackay IR; Shattock M; Bottazzo GF; Holman R
    Lancet; 1997 Nov; 350(9087):1288-93. PubMed ID: 9357409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of newly-onset IDDIM and NIDDIM in subjects aged 25-45 years in Sudan.
    Elbagir MN; Eltom MA; Berne C
    J Intern Med; 1998 Dec; 244(6):443-50. PubMed ID: 9893097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet cell antibodies, but not glutamic acid decarboxylase antibodies, are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes mellitus.
    Sundkvist G; Hagopian WA; Landin-Olsson M; Lernmark A; Ohlsson L; Ericsson C; Ahlmén J
    J Clin Endocrinol Metab; 1994 May; 78(5):1159-65. PubMed ID: 8175973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus.
    Montaña E; Fernandez-Castañer M; Rosel P; Gomez J; Soler J
    Diabete Metab; 1991; 17(5):460-8. PubMed ID: 1752347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus.
    Willis JA; Scott RS; Brown LJ; Forbes LV; Schmidli RS; Zimmet PZ; MacKay IR; Rowley MJ
    Diabetes Res Clin Pract; 1996 Jul; 33(2):89-97. PubMed ID: 8879963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet cell antibodies and insulin autoantibodies in patients treated with oral hypoglycaemic agents.
    Jennings AM; Spencer KM; Dean BM; Wilson RM; Bottazzo GF; Ward JD
    Diabet Med; 1989 Jul; 6(5):434-9. PubMed ID: 2527682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis.
    Groop LC; Bottazzo GF; Doniach D
    Diabetes; 1986 Feb; 35(2):237-41. PubMed ID: 3510930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus.
    Landin-Olsson M; Nilsson KO; Lernmark A; Sundkvist G
    Diabetologia; 1990 Sep; 33(9):561-8. PubMed ID: 2253834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.
    Decochez K; Keymeulen B; Somers G; Dorchy H; De Leeuw IH; Mathieu C; Rottiers R; Winnock F; ver Elst K; Weets I; Kaufman L; Pipeleers DG; Gorus FK;
    Diabetes Care; 2000 Aug; 23(8):1072-8. PubMed ID: 10937500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes.
    Di Bonito P; De Bellis A; Capaldo B; Turco S; Corigliano G; Pace E; Bizzarro A
    Acta Diabetol; 1996 Sep; 33(3):220-4. PubMed ID: 8904929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes; 1996 May; 45(5):622-6. PubMed ID: 8621013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet-cell antibodies and endogenous insulin secretion in Sudanese diabetic children.
    Elamin A; Omer MI; Tuvemo T
    Diabetes Res Clin Pract; 1992 May; 16(2):91-6. PubMed ID: 1600856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of islet cell antibodies in apparently non-insulin dependent diabetic patients; a marker for the later development of insulin dependency.
    Katsura H; Itoh N; Hanafusa T; Kono N; Tarui S
    Med J Osaka Univ; 1991 Mar; 40(1-4):67-71. PubMed ID: 1369659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age.
    Borg H; Gottsäter A; Landin-Olsson M; Fernlund P; Sundkvist G
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3032-8. PubMed ID: 11443164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.